Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 1
1961 4
1962 3
1963 3
1964 6
1965 3
1966 10
1967 5
1968 3
1969 3
1970 6
1971 4
1972 7
1973 11
1974 5
1975 8
1976 6
1977 10
1978 11
1979 4
1980 10
1981 10
1982 15
1983 17
1984 22
1985 15
1986 17
1987 26
1988 35
1989 38
1990 30
1991 50
1992 37
1993 43
1994 48
1995 44
1996 47
1997 49
1998 64
1999 61
2000 65
2001 52
2002 66
2003 60
2004 65
2005 78
2006 82
2007 78
2008 68
2009 100
2010 91
2011 116
2012 113
2013 120
2014 135
2015 97
2016 108
2017 115
2018 115
2019 151
2020 176
2021 187
2022 198
2023 156
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

3,175 results

Results by year

Filters applied: . Clear all
Page 1
Recent Advances in Drug Therapy for Parkinson's Disease.
Murakami H, Shiraishi T, Umehara T, Omoto S, Iguchi Y. Murakami H, et al. Intern Med. 2023 Jan 1;62(1):33-42. doi: 10.2169/internalmedicine.8940-21. Epub 2022 Feb 1. Intern Med. 2023. PMID: 35110492 Free PMC article. Review.
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.
Jänne PA, Baik C, Su WC, Johnson ML, Hayashi H, Nishio M, Kim DW, Koczywas M, Gold KA, Steuer CE, Murakami H, Yang JC, Kim SW, Vigliotti M, Shi R, Qi Z, Qiu Y, Zhao L, Sternberg D, Yu C, Yu HA. Jänne PA, et al. Among authors: murakami h. Cancer Discov. 2022 Jan;12(1):74-89. doi: 10.1158/2159-8290.CD-21-0715. Epub 2021 Sep 21. Cancer Discov. 2022. PMID: 34548309 Free PMC article. Clinical Trial.
Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota.
Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, Nagatake T, Konishi K, Ohno H, Tanisawa K, Mohsen A, Chen YA, Kawashima H, Natsume-Kitatani Y, Oka Y, Shimizu H, Furuta M, Tojima Y, Sawane K, Saika A, Kondo S, Yonejima Y, Takeyama H, Matsutani A, Mizuguchi K, Miyachi M, Kunisawa J. Hosomi K, et al. Among authors: murakami h. Nat Commun. 2022 Aug 18;13(1):4477. doi: 10.1038/s41467-022-32015-7. Nat Commun. 2022. PMID: 35982037 Free PMC article.
Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.
Yu HA, Baik C, Kim DW, Johnson ML, Hayashi H, Nishio M, Yang JC, Su WC, Gold KA, Koczywas M, Smit EF, Steuer CE, Felip E, Murakami H, Kim SW, Su X, Sato S, Fan PD, Fujimura M, Tanaka Y, Patel P, Sternberg DW, Sellami D, Jänne PA. Yu HA, et al. Among authors: murakami h. Ann Oncol. 2024 May;35(5):437-447. doi: 10.1016/j.annonc.2024.02.003. Epub 2024 Feb 17. Ann Oncol. 2024. PMID: 38369013 Free article. Clinical Trial.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Smit EF, Felip E, Uprety D, Nagasaka M, Nakagawa K, Paz-Ares Rodríguez L, Pacheco JM, Li BT, Planchard D, Baik C, Goto Y, Murakami H, Saltos A, Pereira K, Taguchi A, Cheng Y, Yan Q, Feng W, Tsuchihashi Z, Jänne PA. Smit EF, et al. Among authors: murakami h. Lancet Oncol. 2024 Apr;25(4):439-454. doi: 10.1016/S1470-2045(24)00064-0. Lancet Oncol. 2024. PMID: 38547891 Clinical Trial.
2024 Global Symposium on Health Systems Research.
Aiga H, Takizawa I, Topp SM, Murakami H, Barber SL, Kamiya Y, Rasanathan K, Hyder AA. Aiga H, et al. Among authors: murakami h. Bull World Health Organ. 2024 Mar 1;102(3):151-151A. doi: 10.2471/BLT.24.291344. Bull World Health Organ. 2024. PMID: 38434184 Free PMC article. No abstract available.
Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality.
Takahama S, Yoshio S, Masuta Y, Murakami H, Sakamori R, Kaneko S, Honda T, Murakawa M, Sugiyama M, Kurosaki M, Asahina Y, Takehara T, Appay V, Kanto T, Yamamoto T. Takahama S, et al. Among authors: murakami h. Front Immunol. 2023 Oct 18;14:1257113. doi: 10.3389/fimmu.2023.1257113. eCollection 2023. Front Immunol. 2023. PMID: 37920475 Free PMC article.
Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study.
Urata T, Naoi Y, Jiang A, Boyle M, Sunami K, Imai T, Nawa Y, Hiramatsu Y, Yamamoto K, Fujii S, Yoshida I, Yano T, Chijimatsu R, Murakami H, Ikeuchi K, Kobayashi H, Tani K, Ujiie H, Inoue H, Tomida S, Yamamoto A, Kondo T, Fujiwara H, Asada N, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Sawada K, Momose S, Tamaru JI, Nishikori A, Sato Y, Yoshino T, Maeda Y, Scott DW, Ennishi D. Urata T, et al. Among authors: murakami h. Blood Adv. 2023 Dec 26;7(24):7459-7470. doi: 10.1182/bloodadvances.2023010402. Blood Adv. 2023. PMID: 37552496 Free PMC article.
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Karnan S, Ota A, Murakami H, Rahman ML, Wahiduzzaman M, Hasan MN, Vu LQ, Hanamura I, Inoko A, Riku M, Ito H, Kaneko Y, Hyodo T, Konishi H, Tsuzuki S, Hosokawa Y. Karnan S, et al. Among authors: murakami h. Cell Death Discov. 2023 Jul 21;9(1):257. doi: 10.1038/s41420-023-01552-5. Cell Death Discov. 2023. PMID: 37479714 Free PMC article.
3,175 results